Measuring the influence of clinical trials citations on several bibliometric indicators
- 133 Downloads
The practice of publishing clinical trials in scientific journals is common, although not without its critics. This study aims to measure the effect of clinical trials citations on several bibliometric indicators: citations per document (CD); journal impact factor (JIF); relative h-index (RhI) and strike rate index (SRI). We select all the citable documents published in the NEJM, Lancet, JAMA, AIM and BMJ, for the period 2000-2004, and record the citations received by those papers from 2000 to 2005. Our results show that clinical trials have a CD significantly higher than those for conventional papers; JIF is lower when clinical trials are excluded, especially for NEJM, Lancet and JAMA. Finally, both RhI and SRI seem to be unaffected by clinical trials citations.
KeywordsJournal Impact Factor Bibliometric Indicator Citable Document Pharmaceutical Innovation Editorial Material
Unable to display preview. Download preview PDF.
- Barendse, W. (2007), The strike rate index: a new index for journal quality based on journal size and the h-index of citations. Biomedical Digital Libraries, 4(3). http://www.bio-diglib.com/content/4/1/3.
- Cami, J. (1997), Impactolatría: diagnóstico y tratamiento. Medicina Clínica, 109: 515–524.Google Scholar
- DTI, BIA & Department of Health (2003), Bioscience 2015. Improving National Health, Increasing National Wealth. Retrieved January 15, 2007 from: http://www.bioindustry.org/bigtreport/index2.html
- Fassoulaki, A., Paraskeva, A., Papilas, K., Karabinis, G. (2000), Self-citations in six anaesthesia journals and their significance in determining the impact factor. British Journal of Anaesthesia, 84(2): 266–269.Google Scholar
- House of Commons Health Committee, The Influence of the Pharmaceutical industry. Retrieved February 15, 2007 from: http://www.publications.parliament.uk/pa/cm200405/cmselect/cmhealth/42/4202.htm, 2005.
- Lichtenberg, F. R., Pharmaceutical innovation, mortality reduction, and economic growth. In: K. M. Murphy, R. H. Topel (Eds), Measuring the Gains from Medical Research: an Economic Approach (pp. 74–109). Chicago: The University of Chicago Press, 2003.Google Scholar
- OECD, The measurement of scientific and technological activities. Proposed standard practice for surveys on research and experimental development. Paris: OECD, 2002.Google Scholar
- Rousseau, R. (2006), A case study: evolution of JASIS’ h-index (in Chinese). Science Focus, 1(1): 16–17. English version: E-LIS: ID-code 5430.Google Scholar
- Seglen, P.O. (1997), Why the impact factor of journals should not be used for evaluating research. British Medical Journal, 314: 497.Google Scholar
- Smith, R., Roberts, I. (2006), Patient safety requires a new way to publish clinical trials. Public Library of Science Clinical Trials, e6: 1–3.Google Scholar
- Smith, R. (2005a), Medical journals are an extension of the marketing arm of pharmaceutical companies. Public Library of Science Medicine, 2(5): e138.Google Scholar
- Smith, R. (2005b), Curbing the influence of the drug industry: a British view. Public Library of Science Medicine, 2(9): e241.Google Scholar